74 related articles for article (PubMed ID: 8618225)
1. The effect of Beraprost sodium on the survival of subcutaneous transferred jejunum after vascular pedicle interruption in a rat model.
Alexandrou K; Hata Y; Matsuka K; Ito O; Matsuda H; Furuichi H; Ishizu N
J Reconstr Microsurg; 1996 Jan; 12(1):39-46. PubMed ID: 8618225
[TBL] [Abstract][Full Text] [Related]
2. Effect of beraprost sodium (Procylin), a stable prostaglandin I2 analogue, on a dorsal skin flap model in rats.
Alexandrou K; Hata Y; Matsuka K; Matsuda H
Scand J Plast Reconstr Surg Hand Surg; 1996 Mar; 30(1):17-22. PubMed ID: 8711437
[TBL] [Abstract][Full Text] [Related]
3. An experimental study of ischemia following subcutaneous heterotopic intestinal graft: influence of arterial or venous occlusion.
Yano K; Hata Y; Matsuka K; Ito O; Matsuda H; Furuichi H; Shibamoto H
J Reconstr Microsurg; 1992 Sep; 8(5):385-9. PubMed ID: 1404068
[TBL] [Abstract][Full Text] [Related]
4. Formation of independently revascularized bowel segments using the rectus abdominis muscle flap: a rat model for jejunal prefabrication.
Tan BK; Chen HC; Wei FC; Ma SF; Lan CT; See LC; Wan YL
Plast Reconstr Surg; 2002 Feb; 109(2):655-63. PubMed ID: 11818849
[TBL] [Abstract][Full Text] [Related]
5. Effect of a prostaglandin I2 analogue, beraprost sodium, on burn-induced gastric mucosal injury in rats.
Battal MN; Hata Y; Matsuka K; Ito O; Matsuda H; Yoshida Y; Kawazoe T; Nagao M
Burns; 1997 May; 23(3):232-7. PubMed ID: 9232284
[TBL] [Abstract][Full Text] [Related]
6. A stable prostacyclin analog, beraprost sodium, attenuates platelet accumulation and preservation-reperfusion injury of isografts in a rat model of lung transplantation.
Okada Y; Marchevsky AM; Kass RM; Matloff JM; Jordan SC
Transplantation; 1998 Nov; 66(9):1132-6. PubMed ID: 9825806
[TBL] [Abstract][Full Text] [Related]
7. The timing and nature of neovascularization of jejunal free flaps: an experimental study in a large animal model.
Cordeiro PG; Santamaria E; Hu QY; DiResta GR; Reuter VE
Plast Reconstr Surg; 1999 Jun; 103(7):1893-901. PubMed ID: 10359251
[TBL] [Abstract][Full Text] [Related]
8. Reduction of progressive burn injury by a stable prostaglandin I2 analogue, beraprost sodium (Procylin): an experimental study in rats.
Battal MN; Hata Y; Matsuka K; Ito O; Matsuda H; Yoshida Y; Kawazoe T
Burns; 1996 Nov; 22(7):531-8. PubMed ID: 8909753
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of beraprost sodium, a stable prostacyclin analogue, in development of monocrotaline-induced pulmonary hypertension.
Miyata M; Ueno Y; Sekine H; Ito O; Sakuma F; Koike H; Nishio S; Nishimaki T; Kasukawa R
J Cardiovasc Pharmacol; 1996 Jan; 27(1):20-6. PubMed ID: 8656653
[TBL] [Abstract][Full Text] [Related]
10. General pharmacology of beraprost sodium. 2nd communication: effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects.
Murata T; Murai T; Kanai T; Ogaki Y; Sanai K; Kanda H; Sato S; Kajikawa N; Umetsu T; Matsuura H
Arzneimittelforschung; 1989 Aug; 39(8):867-76. PubMed ID: 2510743
[TBL] [Abstract][Full Text] [Related]
11. Experimental study of subcutaneously transferred intestine: effect of the presence of serous membrane on acceptance rate.
Yano K; Hata Y; Matsuka K; Ito O; Matsuda H; Furuichi H; Shibamoto H
J Reconstr Microsurg; 1993 Jan; 9(1):19-25. PubMed ID: 8423558
[TBL] [Abstract][Full Text] [Related]
12. The effects of beraprost Na, a stable prostacyclin analog, on animal models of stroke.
Hirano T; Yamori Y; Kanai N; Umetsu T; Nishio S
Mol Chem Neuropathol; 1992 Aug; 17(1):91-102. PubMed ID: 1388452
[TBL] [Abstract][Full Text] [Related]
13. [Research and development of beraprost sodium, a new stable PGI2 analogue].
Nishio S; Nagase H; Kanou K; Aoki S; Kanbayashi Y
Yakugaku Zasshi; 1997 Aug; 117(8):509-21. PubMed ID: 9306726
[TBL] [Abstract][Full Text] [Related]
14. Treatment of in-stent restenosis with beraprost sodium: an experimental study of short- and intermediate-term effects in dogs.
Seiji K; Tsuda M; Matsuhashi T; Takase K; Miyachi H; Yamada T; Ishibashi T; Higano S; Takahashi S
Clin Exp Pharmacol Physiol; 2009 Dec; 36(12):1164-9. PubMed ID: 19473194
[TBL] [Abstract][Full Text] [Related]
15. Effect of beraprost sodium, a stable prostaglandin I2 analogue, on platelet aggregation in diabetes mellitus.
Kato H; Takashima T; Kishikawa H; Emura S; Ohmori K
Int J Clin Pharmacol Res; 1996; 16(4-5):99-102. PubMed ID: 9172007
[TBL] [Abstract][Full Text] [Related]
16. Beraprost sodium improves survival rates in anti-glomerular basement membrane glomerulonephritis and 5/6 nephrectomized chronic kidney disease rats.
Yamaguchi S; Inada C; Tamura M; Sato N; Yamada M; Itaba S; Okazaki S; Matsuura H; Fujii S; Matsuda F; Goto Y; Mochizuki H; Kurumatani H; Miyamoto M
Eur J Pharmacol; 2013 Aug; 714(1-3):325-31. PubMed ID: 23911885
[TBL] [Abstract][Full Text] [Related]
17. General pharmacology of beraprost sodium. 1st communication: effect on the central nervous system.
Murata T; Sakaya S; Hoshino T; Umetsu T; Hirano T; Nishio S
Arzneimittelforschung; 1989 Aug; 39(8):860-6. PubMed ID: 2510742
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of beraprost sodium, a stable prostacyclin analogue, in diabetic cardiomyopathy.
Ueno Y; Koike H; Nishio S
J Cardiovasc Pharmacol; 1995 Oct; 26(4):603-7. PubMed ID: 8569222
[TBL] [Abstract][Full Text] [Related]
19. Beraprost sodium enhances neovascularization in ischemic myocardium by mobilizing bone marrow cells in rats.
Miyahara Y; Ohnishi S; Obata H; Ishino K; Sano S; Mori H; Kangawa K; Kitamura S; Nagaya N
Biochem Biophys Res Commun; 2006 Nov; 349(4):1242-9. PubMed ID: 16978584
[TBL] [Abstract][Full Text] [Related]
20. Cytoprotective action of beraprost sodium against peroxide-induced damage in vascular endothelial cells.
Kainoh M; Nishio S; Nakadate T
Pharmacology; 1992; 45(2):61-70. PubMed ID: 1523215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
